conv.

← The whole story
Health
AstraZeneca's Etcamah fails late-stage breast cancer trial

AstraZeneca shares drop 3% on trial failure announcement

2 Sep 14 · 10d ago · 3 articles · 1 source · development 2 of 2

The drugmaker's U.S.-listed shares dropped 3% in aftermarket trading following the announcement of the failed trial endpoint.

AstraZeneca shares drop 3% on trial failure announcement
Investing.com News

AstraZeneca Pharmaceutical company developing Etcamah

The whole story articles the bright band is this development · numbered dots are the others · click one to jump

Peak 5 pieces in 3h at Sep 14, 12 AM; 12 pieces over 13 days (11 articles · 1 post) Sep 11, 3 PM — 3 pieces · 3 articles — Newswires 3Sep 11, 6 PM — quietSep 11, 9 PM — quietSep 12, 12 AM — 1 piece · 1 article — Newswires 1Sep 12, 3 AM — quietSep 12, 6 AM — quietSep 12, 9 AM — quietSep 12, 12 PM — quietSep 12, 3 PM — quietSep 12, 6 PM — quietSep 12, 9 PM — quietSep 13, 12 AM — quietSep 13, 3 AM — quietSep 13, 6 AM — quietSep 13, 9 AM — quietSep 13, 12 PM — quietSep 13, 3 PM — quietSep 13, 6 PM — quietSep 13, 9 PM — quietSep 14, 12 AM — 5 pieces · 5 articles — Google News 5Sep 14, 3 AM — quietSep 14, 6 AM — 1 piece · 1 article — Newswires 1Sep 14, 9 AM — 2 pieces · 1 article · 1 post — Mastodon 1, Newswires 1Sep 14, 12 PM — quietSep 14, 3 PM — quietSep 14, 6 PM — quietSep 14, 9 PM — quietSep 15, 12 AM — quietSep 15, 3 AM — quietSep 15, 6 AM — quietSep 15, 9 AM — quietSep 15, 12 PM — quietSep 15, 3 PM — quietSep 15, 6 PM — quietSep 15, 9 PM — quietSep 16, 12 AM — quietSep 16, 3 AM — quietSep 16, 6 AM — quietSep 16, 9 AM — quietSep 16, 12 PM — quietSep 16, 3 PM — quietSep 16, 6 PM — quietSep 16, 9 PM — quietSep 17, 12 AM — quietSep 17, 3 AM — quietSep 17, 6 AM — quietSep 17, 9 AM — quietSep 17, 12 PM — quietSep 17, 3 PM — quietSep 17, 6 PM — quietSep 17, 9 PM — quietSep 18, 12 AM — quietSep 18, 3 AM — quietSep 18, 6 AM — quietSep 18, 9 AM — quietSep 18, 12 PM — quietSep 18, 3 PM — quietSep 18, 6 PM — quietSep 18, 9 PM — quietSep 19, 12 AM — quietSep 19, 3 AM — quietSep 19, 6 AM — quietSep 19, 9 AM — quietSep 19, 12 PM — quietSep 19, 3 PM — quietSep 19, 6 PM — quietSep 19, 9 PM — quietSep 20, 12 AM — quietSep 20, 3 AM — quietSep 20, 6 AM — quietSep 20, 9 AM — quietSep 20, 12 PM — quietSep 20, 3 PM — quietSep 20, 6 PM — quietSep 20, 9 PM — quietSep 21, 12 AM — quietSep 21, 3 AM — quietSep 21, 6 AM — quietSep 21, 9 AM — quietSep 21, 12 PM — quietSep 21, 3 PM — quietSep 21, 6 PM — quietSep 21, 9 PM — quietSep 22, 12 AM — quietSep 22, 3 AM — quietSep 22, 6 AM — quietSep 22, 9 AM — quietSep 22, 12 PM — quietSep 22, 3 PM — quietSep 22, 6 PM — quietSep 22, 9 PM — quietYesterday, 12 AM — quietYesterday, 3 AM — quietYesterday, 6 AM — quietYesterday, 9 AM — quietYesterday, 12 PM — quietYesterday, 3 PM — quietYesterday, 6 PM — quietYesterday, 9 PM — quietToday, 12 AM — quietToday, 3 AM — quietToday, 6 AM — quiet 12
1Etcamah fails primary endpoint in…2AstraZeneca shares drop 3% on trial…
Sep 12Sep 13Sep 14Sep 15Sep 16Sep 17Sep 18Sep 19Sep 20Sep 21Sep 22now · 8:53 AM ET

Reported in the same hours no headline names this development itself — these 4 claims were published in its stretch

  1. 3 outlets Breast cancer pill from AstraZeneca misses mark in pivotal trial

    first by STAT, 10d ago · also Hindustan Times, WSJ

    1 more headline
  2. 2 outlets AstraZeneca’s Etcamah flunks first-line breast cancer trial, adding to oral SERDs’ failure record

    first by Fierce Pharma, 10d ago · also FirstWord Pharma

    1 more headline
  3. 1 outlet STAT+: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and more

    first by STAT News, 9d ago

  4. 1 outlet AstraZeneca's Phase 3 Trial of Combination Treatment for Breast Cancer Fails to Meet Primary Endpoint

    first by marketscreener.com, 10d ago

What people said 1 voice · verbatim

All 2 developments of AstraZeneca's Etcamah fails late-stage breast cancer trial →

NewswiresGoogle NewsMastodon